Search Results
61 items found for "Immunity"
- Chemoattractant receptor signaling in humoral immunity
< GPCR News < GPCRs in Oncology and Immunology Chemoattractant receptor signaling in humoral immunity Published date April 4, 2024 Abstract "Efficient induction of humoral immune responses depends on orchestrated chemoattractant receptors and plays an important role in the control of B cell migration during humoral immune summarize the current understanding of chemoattractant receptor signaling in the context of humoral immunity Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression
< GPCR News < GPCRs in Oncology and Immunology G protein-coupled receptor-mediated signaling of immunomodulation protein-coupled receptors (GPCRs) are essential contributors to tumor growth and metastasis due to their roles in immune Additionally, we focus on the roles of GPCRs in regulating immune checkpoint proteins involved in immune Authors Guang-Hong Qiu, Bin Yu, Mei Ma Tags GPCRs , cancer immune checkpoints , cancer immunotherapy , immune cells , tumor microenvironment .
- PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer
< GPCR News < GPCRs in Oncology and Immunology PAXIP1-AS1 is associated with immune infiltration and lines, but the relationship between PAXIP1-AS1 expression and clinical characteristics, prognosis, and immune regression, Kaplan-Meier method, Cox regression analysis, Gene set enrichment analysis (GSEA), and immuno-infiltration The expression of PAXIP1-AS1 was associated with immune infiltration. low expression of PAXIP1-AS1 was Low expression of PAXIP1-AS1 was significantly associated with poor survival and immune infiltration
- Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency
SCI-IDS predominantly occurs following injury above the T5 levels and eventually leads to systemic immune and the HPA axis was explored by histology and multitissue transcriptomics, and the neuroendocrine-immune Results: The spleen and thymus gland, which are secondary immune organs, were significantly atrophied , indicating that splenic immune function was markedly impaired after high-level SCI. rt1-da, rt1-ba, cd74, cxcr3, vcam1, ccl5, bin1, and IL8) were significantly enriched in MHC-mediated immune
- Targeting adenosine signaling for immuno-oncology
Contest Committee Sponsors GPCR Retreat Program < Back to schedule Targeting adenosine signaling for immuno-oncology signaling through A2A and A2B G protein-coupled receptors is increasingly recognized as an important immune checkpoint in the generation of anti-tumor immunity. CD73 as a new cancer target, and for his translational work in immuno-oncology. , and member of the SAB of Domain Therapeutics, a biopharmaceutical company focused on GPCR in immuno-oncology
- GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis
between GPR37 gene expression and the clinicopathological factors, patient prognosis, tumor-infiltrating immune clinical relevance, and molecular function of GPR37 in glioma using TCGA, STRING, cBioPortal, Tumor Immunity Besides, the "ssGSEA" algorithm was conducted to estimate immune cells infiltration abundance, with ' Furthermore, GPR37 was positively correlated with various immune checkpoints (ICPs). Lai , Huaidong Peng , Yanbin Ke , Zhaotao Wang , Yezhong Wang Tags GPR37 , M2 macrophages , glioma , immune
- Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression through GPCR receptor Mthl10
< GPCR News < GPCRs in Oncology and Immunology Drosophila cytokine GBP2 exerts immune responses and regulates Although GBP1 (CG15917) and GBP2 (CG11395) have been identified in Drosophila melanogaster, immunological Here, we demonstrate that GBP2 replicates the GBP1-mediated cellular immune response from Drosophila Our finding revealed that Drosophila GBP1 and GBP2 control immune responses as well as their own expression Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis
< GPCR News < GPCRs in Oncology and Immunology Identification of a G-protein coupled receptor-related The immunological characteristics of the high- and low-risk groups were analyzed using single-sample GPCRRG expression was correlated with immune infiltration rates. prognostic model elaborates on the roles of GPCRRGs in OV and provides a new tool for prognosis and immune Ruyue Li, Guangqi Li, Meng Wei, Bowei Li, Yongmei Li, Chunfang Ha Tags G protein-coupled receptor , Immune
- Itaconate in host inflammation and defense
< GPCR News < GPCRs in Oncology and Immunology Itaconate in host inflammation and defense Published date March 5, 2024 Abstract "Immune cells undergo rapid and extensive metabolic changes during inflammation Administration of ITA protects against inflammatory diseases and blockade of ITA production enhances antitumor immunity Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
He is a Professor in the Departments of Medicine, Immunology and Medical Biophysics at the University Rottapel’s research interests lies in the elucidation of signal transduction pathways in cancer, immune The Rottapel lab has shown that 3BP2 has pleiotrophic function controlling bone homeostasis, immune cell
- Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer
< GPCR News < GPCRs in Oncology and Immunology Agonists of galanin subtype 2 receptor may prevent pancreatic Stimulation of GAL2 receptor may modulate immune surveillance and inhibits PDAC via cell cycle inhibition Pathways linked to these tumor suppressor proteins may enhance immune surveillance, prevent carcinogenesis Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
< GPCR News < GPCRs in Oncology and Immunology Exploration of prognostic and treatment markers in hepatocellular The tumor immune dysfunction and exclusion (TIDE) algorithm was utilized to evaluate immune infiltration Sensitivity to immunotherapy and common antitumor drugs was predicted via the database Genomics of Drug Patients in the high-risk group exhibited a worse prognosis but demonstrated a more favorable immunotherapy Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- Ep 53 with Dr. Timo De Groof
He currently is focusing on the development of nanobody-based immuno tracers as part of the IMI/EFPIA project entitled "Immune Image".
- Ep 85 with Nicholas Holliday
postdoctoral work that led to Nick's interest in peptide messengers regulating appetite, metabolism, and the immune
- CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes
< GPCR News < GPCRs in Oncology and Immunology CCL5-producing migratory dendritic cells guide CCR5+ monocytes monocytes use CCR5 to follow CCL5-secreting migratory cDCs into the LN, where they regulate DC-mediated immunity Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
< GPCR News < GPCRs in Oncology and Immunology C5aR2 receptor: The genomic twin of the flamboyant C5aR1 is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that tailors immune Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates crystal deposition and kidney injury in oxalate nephropathy in female mice
< GPCR News < GPCRs in Oncology and Immunology Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency In this setting, OGR1 KO mice displayed an increased activation of the immune system and a higher production Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies
< GPCR News < GPCRs in Oncology and Immunology Comparative Analysis of the GNAI Family Genes in Glioblastoma remodeling regulation of actin cytoskeleton organization by the kinase effectors of Rho GTPases" and "Immune Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology
- Ep 146 with Dr Michael Feigin
GPCRs and Cancer Immune Modulation Yamina and Mike had a discussion about their research on GPCRs, specifically They also touched upon the potential of GPCR modulation in stimulating the immune system to fight cancer
- Dr. GPCR Summit 2021 Live Talks
Learn More >> Hydroxycarboxylic acid receptor 3 and GPR84 signaling with potential implications for immune
- Ep 98 with Dr. GPCR Team
As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and immuno-oncology
- Ep 60 with Dr. Josephine (Pina) Cardarelli
She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology
- Ep 150 with Dr GPCR Team
As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and immuno-oncology
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Pharmacology-Physiology, Université de Sherbrooke, Québec, Canada" About Laurent Sabbagh "Laurent holds a Ph.D. in immunology recruited by University of Montreal as an assistant professor working on the role of TNF receptors in immunological Laurent is currently leading DTNA discovery group working on GPCRs in immuno-oncology to discover new Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC
- GPCR Retreat Schedule 2023
Read More Friday, November 3rd / 3:30 PM G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies Rasmussen Rockefeller University Read More Friday, November 3rd / 4:35 PM Targeting adenosine signaling for immuno-oncology
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
GPCR Retreat Program < Back to schedule G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies precision cancer treatments, and to identify novel multimodal strategies to enhance the response to cancer immunotherapies
- Content and Conduct Policy | Dr. GPCR Ecosystem
In emergency situations, we may escalate imminent threats of serious harm to law enforcement.
- Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells
< GPCR News < GPCRs in Oncology and Immunology Autocrine proteinase-activated receptor signaling in PC3 Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology